# Study on the effective dose of alfentanil combined with ciprofol in inhibiting intraoperative body movement responses in patients undergoing breast lump resection

**Authors:** Fei Li, Yingying Lu, Gang Lu, Jiaqi Gu, Yumin Zhu

PMC · DOI: 10.3389/fmed.2025.1720728 · Frontiers in Medicine · 2026-01-07

## TL;DR

This study finds the effective dose of alfentanil combined with ciprofol to prevent body movement during breast surgery.

## Contribution

It quantifies the effective alfentanil dose for suppressing movement when used with ciprofol in breast lumpectomy.

## Key findings

- The median effective dose (ED50) of alfentanil was 13.396 μg/kg.
- The 95% effective dose (ED95) was 15.752 μg/kg.
- No postoperative adverse reactions were observed in participants.

## Abstract

Alfentanil and ciprofol are used in combination for intravenous anesthesia, but the effective dose of alfentanil required to suppress movement during surgery when co-administered with ciprofol is not well-defined. This study aimed to determine the effective dose of alfentanil, combined with ciprofol, required to inhibit body movement responses in patients undergoing breast lumpectomy.

Patients scheduled for elective breast lumpectomy uswere selected. Ciprofol was administered intravenously at anesthesia induction, and alfentanil was given using the sequential method with an initial dose of 10 μg/kg and a dose gradient of 1 μg/kg. The dosage of alfentanil, the incidence of intraoperative respiratory depression, hypotension requiring treatment, and bradycardia were recorded. Postoperative adverse reactions were assessed and recorded. Probit regression analysis was used to calculate the effective dose.

The median effective dose (ED₅₀) of alfentanil for inhibiting intraoperative body movement was calculated to be 13.396 μg/kg, with a corresponding 95% effective dose (ED95) of 15.752 μg/kg. During the surgical procedure, no patients required therapeutic intervention for either intraoperative hypotension or bradycardia. However, three patients developed respiratory depression. Notably, no postoperative adverse reactions were documented in any of the study participants.

The ED50 of alfentanil combined with ciprofol for intravenous anesthesia to suppress movement during breast lumpectomy is 13.396 μg/kg, and the ED₉₅ is 15.752 μg/kg.

http://www.chictr.org.cn, ChiCTR2500109829.

## Linked entities

- **Chemicals:** alfentanil (PubChem CID 51263), ciprofol (PubChem CID 86301664)

## Full-text entities

- **Diseases:** bradycardia (MESH:D001919), hypotension (MESH:D007022), respiratory depression (MESH:D012131)
- **Chemicals:** Alfentanil (MESH:D015760), Ciprofol (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819824/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12819824/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12819824/full.md

---
Source: https://tomesphere.com/paper/PMC12819824